Bad Dreams, Nutrition, and 5-hydroxytryptophan

G. Douglas Andersen, DC, DACBSP, CCN

Volume 23, number 1, 1/1/05, page 30

I remember as a child I would have a bad dream that would cause me to wake up. I would go down the hall to my parents' room (I cannot remember if I knocked or not), go to my mom's side of the bed, and say "Mom, I had a bad dream." She would then move and let me get in the bed between her and my father. I would immediately feel safe and fall back to sleep (it never crossed my mind that I may not have been welcomed). In my case, this happened no more than once a year, approximately between the ages of 3 and 8.

Over the years I have had a few patients who mentioned that their children had nightmares on a much more regular basis (3 to 6 times per month). Until now, my only recommendations were (1) make an appointment with a pediatrician to rule out disease, (2) determine if a specific incident was provocative and, if so, seek out psychotherapy, (3) provide parental support and reassurance, and (4) in the absence of disease, disorder, or an identified external cause, consult a sleep specialist.

The Study1
Researchers from the University of Rome Sleep Center in the Department of Neurology in Italy identified 45 children ages 3 to 10 who suffered from nightmares that caused them to wake up at least 3 times per month for at least 3 months. The children in this study were not taking any sleep medications, nor did rigorous examinations uncover any disease processes. Thirty-one of the subjects received 2 mg/kg/bw of L 5 hydrotryptophan (5-HTP) at bedtime. Fourteen children acted as controls. In the control group parents were told the problem was benign, nothing to worry about, and would cease when their child reached adolescence.

5-HTP group at 1 month:
16/31 had total resolution of nightmares
13/31 had at least 50% fewer nightmares
2/31 had no response

Control group at 1 month:
2/14 had total resolution of nightmares
2/14 had at least 50% fewer nightmares
10/14 had no change in the number of nightmares

5-HTP group at 6 months:
24/31 had total resolution of nightmares
2/31 had at least 50% fewer nightmares
5/31 continued to have nightmares
(3/13 who had a 50% reduction after 1 month stopped responding)

Control group at 6 months:
0/14 had total resolution of nightmares
5/14 had at least 50% fewer nightmares
9/14 had no change in the number of nightmares per month

It is known that 5-HTP is a serotonin precursor. In children suffering from nightmares, abnormalities in the serotoninergic system may be causal.2

The authors stated that due to the lack of side effects and development of tolerance during long-term use, 5-HTP was selected as a possible interventional aid. The dosing was also low - 2 mg/kg/bw, especially when compared to commonly used amounts of other amino acids.

There were limitations to the study, the most important of which is the association between tryptophan products and eosinophilia-myalgia syndrome (EMS). Although it is extremely rare in 5-HTP products, EMS has been reported.3 The authors of this study stated that improved purification and analysis methods have resulted in unadulterated pharmaceutical grade preparations of 5-HTP that are safe. Other limitations of this study were the amount of subjects (45) and the fact that it was an open-label trial. I hope these findings provoke a double blind, placebo-controlled trial with a larger sample size. Finally, anyone who takes 5-HTP should only purchase this product from major nutrition companies and/or from companies that cater to healthcare professionals.

  1. Bruni, O., Ferri, R., Miano, S., Verrillo, E. L-5-hydroxytryptophan Treatment of Sleep Terrors in Children. European Journal of Pediatrics. 2004. 163; 402-207.
  2. Adrien, J. The Serotoninergic System and Sleep-Wakefulness Regulation. In Kales, A. (Ed) The Pharmacology of Sleep. New York: Springer, Berlin, and Heidelberg. 1995.
  3. Michelson, D., Page, S.W., Casey, R., et al. An Eosinophilia-myalgia Syndrome-related Disorder Associated with Exposure to L-5-hydroxytryptophan. J Rheum. 1994. 21; 2261-65.

916 E. Imperial Hwy.
Brea, CA. 92821

(714) 990-0824
Fax: (714) 990-1917

Copyright 2004, G. Douglas Andersen, DC, DACBSP, CCN, 916 E. Imperial Hwy, Brea, CA 92821, (714) 990-0824